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Background: Numerous studies have shown decreased perfusion in the prefrontal cor-
tex following mild traumatic brain injury (mTBI). However, similar hypoperfusion can also
be observed in depression. Given the high prevalence of depressive symptoms following
mTBI, it is unclear to what extent depression influences hypoperfusion in TBI.
Methods: MildTBI patients without depressive symptoms (mTBI-noD, n=39),TBI patients
with depressive symptoms (mTBI-D, n=13), and 15 patients with major depressive disor-
der (MDD), but no TBI were given 99m T-ECD single-photon emission computed tomog-
raphy (SPECT) scans within 2 weeks of injury. All subjects completed tests of information
processing speed, complex attention, and executive functioning, and a self-report ques-
tionnaire measuring symptoms of psychological distress. Between-group comparisons of
quantified SPECT perfusion were undertaken using univariate and multivariate (partial least
squares) analyses.
Results: mTBI-D and mTBI-noD groups did not differ in terms of cerebral perfusion. How-
ever, patients with MDD showed hypoperfusion compared to both TBI groups in several
frontal (orbitofrontal, middle frontal, and superior frontal cortex), superior temporal, and
posterior cingulate regions. The mTBI-D group showed poorer performance on a measure
of complex attention and working memory compared to both the mTBI-noD and MDD
groups.
Conclusion: These results suggest that depressive symptoms do not affect SPECT per-
fusion in the sub-acute phase following a mild TBI. Conversely, MDD is associated with
hypoperfusion primarily in frontal regions.
Keywords:TBI, depression, SPECT, neuropsychology, attention, partial least squares
INTRODUCTION
Mild traumatic brain injury (mTBI) can be associated with cog-
nitive dysfunction, post-concussive symptoms, and mood distur-
bances [for review, see Ref. (1)]. Cognitive deficits following mTBI
usually occur on measures of attention, memory, and processing
speed (2), with deficits typically resolving within the first 3 months
of recovery. In terms of mood, depressive symptoms are the most
frequent complaint, with approximately 26% of mTBI patients
meeting the criteria for major depressive disorder (MDD) and
an additional 20% reporting minor depressive symptoms 1-year
post-injury (3, 4). Persisting cognitive deficits and disturbed mood
are associated with poorer long-term outcome (4, 5).
Functional neuroimaging has consistently shown abnormal-
ities in prefrontal regions in mTBI, which are associated with
cognitive deficits. For example, functional magnetic resonance
imaging (fMRI) activation is attenuated in mTBI patients when
completing complex tasks such as the n-back, a measure of work-
ing memory (6, 7). Similarly, cerebral perfusion measured via
single-photon emission computed tomography (SPECT) shows
hypoperfusion in frontal regions that is associated with lower neu-
ropsychological test scores (8–10). Studies measuring resting-state
fMRI in mTBI also show decreased activity at rest following TBI
compared to healthy controls (11, 12).
Notably, many of the regions affected by TBI are also associated
with MDD without comorbid TBI. For example, MDD, in gen-
eral, is also associated with frontal hypoperfusion on SPECT scans
(13–16), decreased activation during cognitive task performance
(17, 18), and alterations in resting-state activity (19, 20). Given
these parallel findings among individuals with mTBI and MDD,
it is unclear from a clinical standpoint whether decreased cerebral
activity following mTBI may be attributed to neurological insult or
depressive features. In addition, it is unclear whether patients with
mTBI and concurrent depressive symptoms would show lower
perfusion compared to patients with mTBI or MDD only.
Few studies have explored how depression may influence brain
imaging in patients with mTBI, with most studies measuring
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structural differences among TBI patients with or without MDD
(21–23). For example, Maller et al. (23) found decreased frontal
white matter integrity in depressed TBI patients compared to
non-depressed TBI patients, and Hudak et al. (22) found that
the severity of depressive symptoms in a group of TBI patients
correlated with atrophy in the orbitofrontal cortex. In one of the
few studies examining the effect of depression on functional acti-
vation in TBI, Chen et al. (24) found that within a sample of
concussed athletes, increasing severity of depressive symptoms was
associated with attenuated prefrontal activation during a working
memory task. However, to date, there have been no studies specifi-
cally examining how depressive symptoms post-TBI affect SPECT
perfusion.
Given the uncertainty on how to interpret SPECT hypoper-
fusion in mTBI patients with concurrent depressive symptoms,
and the fact SPECT remains an investigational tool for use in this
patient population (25), we undertook a study with the aim of
teasing apart the role of these competing variables on cerebral
perfusion. Specifically, we compared cerebral perfusion between
mTBI patients who did or did not endorse depressive symptoms
on a general psychiatric screen and patients with MDD, using both
quantitative measures of SPECT perfusion, as well as standard
clinical ratings. We posited that group differences in perfusion
would emerge primarily in medial prefrontal regions across all
groups, with MDD patients exhibiting the lowest levels of per-
fusion, mTBI patients without depression showing the highest
perfusion values, and mTBI patients with depressive symptoms
exhibiting intermediary levels of perfusion.
MATERIALS AND METHODS
SUBJECTS
Fifty-two patients who sustained a mild TBI were recruited
from the emergency room at Sunnybrook Health Sciences Centre
(Table 1). Mild TBI was defined according to established criteria
(26) as a score of 13 or greater on the Glasgow Coma Scale, loss of
consciousness of <30 min, and a post-traumatic amnesia of 24 h
or less. Diagnosis of mTBI was done through clinical interview
by an experienced neuropsychiatrist. Exclusion criteria were the
presence of a comorbid condition that could affect cognitive func-
tioning (i.e., cerebrovascular disease), the presence of additional
traumatic injuries or complications requiring hospital admission
(e.g., fractures), current antidepressant use, and current substance
abuse assessed by self-report or a urine screen for illicit substances.
In addition, 15 patients with a diagnosis of MDD based on
DSM-IV criteria were recruited from the outpatient psychiatry
clinic at Sunnybrook. Patients with MDD were excluded if they
had a previous history of TBI or other neurological insult.
CLINICAL/COGNITIVE ASSESSMENT
Basic demographic information (age, sex, level of education) was
obtained for each patient. Computerized versions of the Stroop
test, symbol digit modalities test (SDMT), and paced visual serial
addition test (PVSAT) were sent from a desktop computer to all
patients (27). The Stroop test is a classic measure of response inhi-
bition and executive functioning, requiring subjects to view a series
of color names shown in congruent or incongruent colored ink and
to respond by naming the color of the ink the word is shown in and
not read the word. The SDMT is a measure of information process-
ing speed and requires subjects to fill in a set of number–symbol
pairings as quickly as possible. The PVSAT is a visual analog of the
paced auditory serial addition test, a measure of complex atten-
tion and working memory. In this version, subjects saw a stream
of single digit numbers and had to continuously report the sum of
the last two numbers displayed. The National Adult Reading Test
(NART) was given to estimate premorbid intellectual abilities (28).
Psychological distress was elicited with the 28-item General
Health Questionnaire [GHQ; (29)]. This self-report questionnaire
is used as a general screening tool of psychological distress and
is scored on a 4-point scale and contains four subscales (anxi-
ety, depression, social dysfunction, and somatic concern) of seven
questions each with a choice of four responses per question. We
used the method of scoring (0–0–1–1) advocated by the scale’s
developer. Total scores, therefore, range from 0 to 28 with higher
scores more indicative of psychopathology.
IMAGING ACQUISITION
Single-photon emission computed tomography imaging was
acquired within 2 weeks of neurological insult, using a triple-head
gamma camera system (Prism 3000XP; Phillips Medical Systems
Inc., Cleveland, OH, USA), 30–45 min after injection of 20 mCi
(740 MBq) of Technetium-99m ethyl cysteinate dimer (99mTc-
ECD). Acquisition consisted of 120 slices obtained continuously
over 360° (acquisition matrix= 128× 128 pixels, zoom of 1.0),
with an image resolution of 9.7 mm full-width half-maximum.
Total acquisition time was 18.7 min. Reconstruction was per-
formed using a ramp-filtered back projection algorithm with a
3D Wiener postfilter. Ellipses were fit to the approximate loca-
tion on the outline of the head in each axial image, with an
attenuation correction applied to each image, resulting in a voxel
size of 2.17 mm× 2.17 mm× 3.56 mm. SPECT images were co-
registered to an ROI SPECT template containing 75 ROIs using
Automated Image Registration (AIR, version 3.0) (30). The tem-
plate was created by co-registering a T1 MRI of a middle-aged male
healthy control representative of the normal population, along
the AC–PC axis to their SPECT scan, using a 12-parameter affine
model and least squares fit with intensity scaling.
Finally, within each subject, for each ROI, a quantified metric
of regional cerebral blood flow was calculated by measuring the
mean perfusion count within the whole ROI and dividing it by the
mean perfusion count within the cerebellum (31).
ANALYSIS
The 52 mTBI patients were classified into mTBI who reported any
level of depressive symptoms (mTBI-D; n= 13) and mTBI who
did not report any depressive symptoms (mTBI-noD; n= 39),
based on the median of the depression subscale scores on the
General Health Questionnaire, using the 0–0–1–1 scoring method
outlined by the scale’s authors. The median depressive score was
0, therefore, we used a score of 1 or higher to differentiate between
mTBI patients with depressive symptoms and mTBI patients with-
out any depressive symptoms. Although the GHQ is used as a
screening tool for psychological distress, factor analysis has con-
firmed that the depressive subscale is consistently found across
several cultures (32). Demographical and clinical variables were
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Table 1 | Demographical and clinical information forTBI patients with depressive symptoms,TBI patients without depressive symptoms, and
patients with MDD.
TBI-noD TBI-D MDD F-test/X 2 pValue
M (SD) M (SD) M (SD)
n 39 13 15
Age 40.31 (10.15) 37.54 (10.20) 45.93 (8.55) 2.79 0.07
% Male 66.7 46.2 33.3 5.41 0.07
Estimated IQ (NART) 108.85 (11.09) 107.54 (11.81) 115.53 (8.09) 2.60 0.08
GCS <1 0.835
13 3 1 –
14 5 1 –
15 28 11 –
LOC <1 0.472
None 0 0 –
Altered consciousness 19 8 –
<30 min 19 5 –
PTA 1.53 0.464
None 9 1 –
<1 h 21 8 –
<24 h 9 4 –
% Prior psychiatric diagnosis 7.70% 15.40% – <1 0.415
% Positive SPECT ratings 28.20% 46.20% 33.30% 1.43 0.49
Cognitive measures
Stroop (completion time, s) 24.86 (7.49) 30.65 (15.35) 28.37 (9.41) 1.95 0.15
SDMT (completion time, s) 101.75 (22.37) 117.72 (44.69) 108.78 (16.17) 1.78 0.18
PVSAT (# errors) 7.97 (8.89) 18.08 (15.88) 9.00 (8.45) 4.61 <0.05
Symptomatology measures
GHQ-Somatic Subscale 4.05 (1.83) 6.00 (0.91) 3.20 (2.08) 9.34 <0.005
GHQ-Anxiety Subscale 2.05 (2.29) 5.00 (1.87) 3.47 (2.72) 8.35 <0.005
GHQ-Social Dysfunction Subscale 3.10 (2.41) 6.08 (1.70) 4.33 (2.99) 7.46 <0.005
GHQ-Depression Subscale 0 (0) 1.69 (0.63) 4.33 (2.58) – –
GHQ-Total Score 9.21 (5.50) 18.77 (3.52) 15.33 (9.39) 13.32 <0.005
mTBI-noD, TBI non-depressed group; mTBI-D, TBI depressed group; MDD, major depressive disorder group; NART, National Adult Reading Scale; GCS, Glasgow
Coma Scale; LOC, loss of consciousness; PTA, post-traumatic amnesia; SPECT, single-photon emission computed tomography; SDMT, Symbol Digit Modalities Test;
PVSAT, Paced Visual Serial Addition Test; GHQ, General Health Questionnaire.
Statistically significant effects are shown in bold.
compared between mTBI-D, mTBI-noD, and MDD groups with
one-way ANOVAs or Chi-square statistics, using SPSS version 20.
IMAGING ANALYSIS
We compared quantified SPECT perfusion values across mTBI-
D, mTBI-noD, and MDD groups using one-way ANOVAs. We
focused on six regions bilaterally based on the established involve-
ment of frontal and temporal hypoperfusion in both mild TBI and
MDD. These regions (12 in total) included bilateral inferior frontal
gyri, middle frontal gyri, superior frontal gyri, anterior cingulate
gyri, orbitofrontal gyri, and hippocampi. We controlled multiple
comparisons across the ROIs using a Bonferroni correction, with
a significant p value set at 0.004. In addition, for any significant
ROIs, Bonferroni-corrected tests of simple effects were conducted
to compare SPECT perfusion across pairs of groups.
Single-photon emission computed tomography images were
also analyzed using partial least squares [PLS; (33–35)]. PLS is a
multivariate, data-driven technique that extracts latent variables
that maximize the covariance between two matrices of data using
singular value decomposition and is particularly suited for sit-
uations when the number of variables far exceeds the number of
observations/subjects, and when many of those variables are highly
correlated (i.e., different ROIs). Rather than the univariate method
of running a large number of statistical tests on discrete regions or
voxels, in PLS the entire group of ROIs is treated as a large matrix
of data along with other data (in this case, vectors denoting group
membership). These matrices are combined and decomposed via
singular value decomposition to determine if there exists latent
variable(s) that maximally explain the covariance between data
matrices. For this study, we employed mean-centered PLS, which
extracts patterns of SPECT perfusion across all ROIs, which max-
imally differentiate patient groups (i.e., how much variance in
perfusion is accounted for by group membership). The analysis
is similar to discriminant function analysis, such that in PLS the
latent variables serve a similar role as discriminate functions. Sev-
eral other studies have used PLS to differentiate between patient
populations, using various imaging modalities (33). Using a data-
driven technique such as PLS allows us to provide additional,
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hypothesis-free evidence to determine (a) whether patterns of
brain perfusion can differentiate between different patient popu-
lations, (b) how different patient groups are differentiated, and (c)
whether those brain regions include a priori ROIs. The significance
of extracted latent variables is estimated using permutation test-
ing, in which behavioral observations are shuffled within subjects,
to create a distribution for comparison to the original extracted
variable (i.e., whether the latent variable from the observed, exper-
imental data is significantly different from a distribution of noise).
For this study, 1000 permutations with a threshold of p< 0.05 were
used. Because the statistical analysis is done in a single step, there
is no need for correcting multiple comparisons across the whole
brain. In addition, the reliability of each ROI’s contribution to the
latent variables (i.e., salience) is calculated via bootstrap resam-
pling, which estimates the standard error of the salience of each
ROI’s contribution to the latent variable. Salience-to-standard
error ratios derived through bootstrap resampling are approxi-
mately equivalent to z-scores and reflect the consistency of that
brain region’s contribution to the extracted pattern. 500 bootstrap
resamplings were used to construct the saliences; ROIs were con-
sidered reliable if the salience to standard error ratio exceeded 3.5
corresponding to a p value of 0.0005.
In addition, all SPECT scans were rated clinically as nor-
mal or abnormal by a radiologist or nuclear medicine specialist,
who were both blind to group membership. All research was
approved by the Research Ethics Board at Sunnybrook Health Sci-
ences Center and all patients provided informed consent prior to
participating.
RESULTS
There were no significant differences between groups in terms
of age, sex, or estimated IQ (Table 1). In addition, mTBI-D
and mTBI-noD groups did not differ on indices of TBI severity,
i.e., GCS, LOC, duration of PTA, or the frequency of a premorbid
psychiatric diagnosis.
In terms of cognitive performance, there was a significant
overall difference between patient groups on the PVSAT, a mea-
sure of complex attention and working memory, F(2,63)= 4.61,
p= 0.014: tests of simple effects confirm that mTBI-D patients
showed more impaired performance (i.e., increased number of
errors) than both the mTBI-noD patients (p< 0.005) and the
MDD patients (p< 0.005) (Table 1).
Furthermore, there were no differences between groups in
the percentage of patients with positive SPECT findings based
on clinical ratings F(2,63)= 1.43, p= 0.49, suggesting that visual
inspection by experienced radiologists is not sufficiently sensitive
to capture any group differences in perfusion due to depressive
symptoms (Table 1).
Conversely, one-way ANOVAs comparing quantified SPECT
perfusion across groups showed significant differences in most of
the frontal ROIs, with differences in the right orbitofrontal cortex,
and left middle and superior frontal gyri surviving correction for
multiple comparisons (Table 2). Pairwise comparison of perfu-
sion revealed a similar pattern across these significant regions; the
MDD group showed lower perfusion compared to both the mTBI-
D or mTBI-noD groups and the mTBI groups did not significantly
differ from each other (Figure 1).
A similar picture emerged using a data-driven multivariate
analysis. PLS analysis on SPECT perfusion across the whole
brain yielded a pattern of perfusion that significantly dissoci-
ated the mTBI-D and mTBI-noD groups from the MDD group
(p= 0.004). Crucially, the regions significantly contributing to this
pattern had notable overlap with the a priori ROIs and included
the bilateral orbitofrontal gyri, right inferior frontal gyrus, bilat-
eral middle frontal gyri, left superior frontal gyrus, and right
anterior cingulate cortex. In addition, other areas contributing to
Table 2 | Mean SPECT perfusion in regions of interest inTBI patients with or without depressive symptoms and patients with MDD.
SPECT perfusion F-test pValue
mTBI-noD mTBI-D MDD
M (SD) M (SD) M (SD)
L Anterior cingulate gyrus 0.765 (0.084) 0.743 (0.098) 0.709 (0.092) 2.14 0.126
R Anterior cingulate gyrus 0.774 (0.093) 0.764 (0.128) 0.734 (0.104) <1 0.449
L Inferior frontal gyrus 0.967 (0.081) 0.991 (0.084) 0.093 (0.086) 4.54 0.014
R Inferior frontal gyrus 0.971 (0.084) 0.981 (0.114) 0.889 (0.077) 5.32 0.007
L Middle frontal gyrus 0.993 (0.082) 1.00 (0.098) 0.911 (0.065) 6.29 0.003
R Middle frontal gyrus 0.982 (0.086) 0.970 (0.105) 0.901 (0.072) 4.78 0.012
L Superior frontal gyrus 0.909 (0.084) 0.894 (0.069) 0.824 (0.073) 6.40 0.003
R Superior frontal gyrus 0.869 (0.086) 0.867 (0.060) 0.806 (0.073) 3.60 0.033
L Orbital gyrus 0.801 (0.054) 0.819 (0.069) 0.750 (0.056) 5.85 0.005
R Orbital gyrus 0.878 (0.060) 0.885 (0.080) 0.811 (0.035) 7.58 0.001
L Hippocampus 0.639 (0.065) 0.635 (0.055) 0.657 (0.060) <1 0.703
R Hippocampus 0.614 (0.066) 0.614 (0.068) 0.605 (0.074) <1 0.866
mTBI-noD, mild traumatic brain injury patients without depressive symptoms.
mTBI-D, mild traumatic brain injury patients with depressive symptoms.
MDD, major depressive disorder patients.
Statistically significant effects are shown in bold.
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FIGURE 1 | Pairwise comparisons of SPECT perfusion in regions of interest with significantly different activity across patient groups.
Table 3 | Brain regions comprising the pattern of SPECT perfusion that
significantly differentiatesTBI patient groups from the MDD group,
using mean-centered partial least squares.
Brain Region BSR
L Orbitofrontal gyrus −3.5472
R Orbitofrontal gyrus −5.467
R Inferior frontal gyrus −3.8382
L Middle frontal gyrus −4.3717
L Middle frontal gyrus −3.8253
R Middle frontal gyrus −3.5312
L Superior frontal gyrus −3.8617
R Anterior cingulate cortex −4.0715
L Posterior cingulate cortex −3.5965
R Posterior cingulate cortex −3.7877
R Superior temporal gyrus −3.9391
BSR, bootstrap ratio; the ratio of salience to bootstrap-derived standard error
is equivalent to a z-score of the contribution of each brain region to the latent
variable differentiating mTBI-D and mTBI-noD groups from the MDD group.
this pattern included the right superior temporal gyrus and bilat-
eral posterior cingulate cortices (Table 3; Figure 2). For all these
regions, perfusion was significantly lower in MDD patients com-
pared to mTBI-noD and mTBI-D patients, bolstering the notion
that depressive symptoms do not affect SPECT perfusion in the
sub-acute phase following mTBI.
To determine whether SPECT perfusion was associated with
individual differences in cognitive performance, we calculated the
correlation between perfusion in the right orbitofrontal gyrus and
PVSAT scores, within each patient group. However, there were no
significant correlations between perfusion and PVSAT scores in
FIGURE 2 | Brain regions significantly differentiating depressed and
non-depressedTBI patients from major depressive disorder patients.
Regions in blue show lower perfusion levels in depressed patients
compared to both mTBI patient groups.
any group (mTBI-D, r = 0.03, p= 0.88; mTBI-noD, Spearman’s
ρ=−0.14, p= 0.65; MDD, Spearman’s ρ= 0.45, p= 0.1).
DISCUSSION
The most notable findings from this study were that quantified
measures of SPECT perfusion failed to distinguish between mTBI
subjects with and without depressive symptoms; however, signifi-
cant hypoperfusion was found in subjects with a major depression
but no TBI. These results were consistent using both univariate
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analysis of a priori ROIs and using a data-driven multivariate
method. In addition, we found that mTBI patients with depressive
symptoms showed worse performance on a measure of complex
attention compared to both mTBI patients without depressive
symptoms and MDD patients.
To our knowledge, this is the first investigation into the effect
of depressive symptoms on SPECT perfusion in mTBI. Based on
prior research showing both TBI and MDD subjects have pre-
frontal and temporal hypoperfusion (8, 16), we hypothesized that
these regions would also be implicated in mTBI patients with
depressive symptoms, however, SPECT perfusion did not differ
between mTBI patients with or without depressive symptoms.
Only a handful of studies in the TBI literature have examined cere-
bral correlates of depression, but the focus has been on structural
measures (21–23). Maller et al. (23) compared diffusion tensor
imaging (DTI) between TBI patients with MDD, TBI patients
without MDD, patients with MDD but no TBI, and healthy con-
trols, and found that TBI patients with MDD showed increased
radial diffusivity (i.e., decreased white matter integrity) in the
corpus callosum and dorsolateral prefrontal white matter com-
pared with TBI patients without MDD. In addition, patients with
MDD showed a similar pattern of increased diffusivity compared
to healthy controls, suggesting that these findings are associated
with MDD in general, independent of any TBI-related patho-
physiological processes. Hudak et al. (22) examined individual
differences in Beck Depression Inventory (BDI-II) scores within
a group of TBI patients and found correlations with atrophy in
the orbitofrontal cortex, suggesting that gray matter loss in this
region following mTBI may be partially attributed to depression.
Other studies examining depressive symptoms and neuroimag-
ing in TBI have similarly examined patients in the chronic phase
(24). Thus, these findings cannot be directly compared with our
study, as we obtained SPECT images in the sub-acute phase rather
than several months post-injury. One possibility is that within the
TBI patient population, neuroimaging may only be sensitive to
persisting depressive symptoms and not the presence psychiatric
complaints in the more acute phases.
Similarly, it should be noted that the endorsement of depres-
sive symptoms is not equivalent to a diagnosis of MDD, both in
terms of symptom severity and duration. It may be the case that
reporting depressive symptoms in the sub-acute phase following a
TBI is tied more closely to the presence of post-concussive symp-
toms (i.e., somatic, cognitive complaints), factors that may differ
from the factors contributing to MDD in those without cerebral
trauma. Our data are consistent with this notion in that there
were no significant differences in SPECT perfusion among MDD
patients and either mTBI groups, perhaps suggesting separate eti-
ologies and neural substrates associated with depressive symptoms
in these groups.
Our finding of decreased cerebral perfusion in the MDD group
is consistent with data in the general psychiatry literature showing
that MDD is associated with cerebral abnormalities in prefrontal
and temporal regions, specifically, orbitofrontal cortex, anterior
cingulate cortex, middle and superior frontal regions, as well as
the hippocampus and amygdala (17–19, 36). In terms of SPECT,
decreased perfusion is typically observed in prefrontal regions,
with perfusion levels correlating with symptom severity (13, 37)
[but see Ref. (20)]. Current theories of depression implicate limbic
and prefrontal regions in a dynamic interaction between altered
resting-levels of neural activity and heightened reactivity to emo-
tional stimuli, corresponding to the ruminative tendencies and
negative biases commonly observed in these patients (19, 20).
Although existing studies have only compared SPECT perfusion
between MDD patients and healthy controls, given that both TBI
and MDD are associated with frontal hypoperfusion, our data
indicate that the magnitude of frontal hypoperfusion in MDD is
relatively greater than the decrease in perfusion observed following
mTBI.
Taken together, the present findings suggest that mild levels of
depressive symptoms following mTBI do not contribute to sub-
acute cerebral hypoperfusion, as quantified measures of SPECT
perfusion were unable to distinguish among mTBI patients with or
without depressive symptoms. Thus, it seems that in patients with
mTBI, SPECT is not sufficiently sensitive to differentiate the pres-
ence or absence of milder levels of depressive symptoms. Whether
SPECT is able to distinguish between mTBI patients with or with-
out major depression is not clear; extrapolating from our present
findings and given the ability of other imaging modalities to dis-
tinguish TBI patients with MDD from those without MDD, we
posit that quantified metrics of SPECT perfusion may indeed be
able to make such distinctions.
Although SPECT remains an investigational tool for this patient
population (25), the results from the present study suggest that
it may have clinical utility that warrants further exploration.
Indeed, a recent systematic review found that SPECT is potentially
more sensitive to cerebral dysfunction not always evident on non-
contrast CT or MRI. Moreover, SPECT was found to have almost
100% negative predictive ability (38). It may be that SPECT or
other measures of cerebral perfusion or resting-state neural activ-
ity could be more sensitive to cerebral dysfunction compared to CT
or MRI in the more acute/sub-acute phases, when morphological
differences likely would not yet have fully emerged.
In contrast, SPECT perfusion measured by clinical ratings was
not able to differentiate any patient groups, suggesting that the
differences in perfusion may only emerge using quantified metrics
and multivariate analysis rather than visual ratings. Multivariate
approaches to analyzing brain imaging are becoming more com-
mon, as our understanding of the complex networks underlying
psychopathology continues to develop (36, 39, 40). Advantages of
PLS are that it is a data-driven method with few a priori assump-
tions and the resultant patterns of brain activity are constrained to
the topic of interest, in this case, maximally differentiating patient
groups. Other multivariate methods such as independent compo-
nents analysis also have few prior assumptions but require some
subjective selection with respect to which networks to analyze
further (41).
An additional finding was that TBI patients with depres-
sive symptoms showed poorer cognitive performance compared
to both TBI patients without depressive symptoms and MDD
patients. This is consistent with evidence showing that the pres-
ence of mood disturbances in TBI is associated with cognitive
dysfunction (42), poorer long-term outcome (4), and gray matter
atrophy (43). However, the group differences in cognitive perfor-
mance did not mirror group differences in SPECT and SPECT
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perfusion was not correlated with PVSAT scores, suggesting that
it is not sensitive to changes in cognitive performance associated
with disturbed mood.
A limitation to the present investigation was the relatively small
sample size. In addition, although the GHQ is a widely used screen-
ing tool for psychological distress, it does not provide a more
in-depth assessment of depressive symptomatology. Future studies
should compare SPECT perfusion in TBI patients with and with-
out a formal diagnosis of MDD. Furthermore, we did not have a
healthy control sample with which to compare perfusion from the
different patient populations. Given that most existing research on
TBI patients and SPECT used clinical ratings of perfusion, there
are no existing studies using equivalent methods to provide a nor-
mal range of normal perfusion values in a healthy population. Also,
although there were no significant differences between groups in
terms of age or IQ, there was a numerical trend toward increasing
age and IQ in the MDD group. Subsequent studies should uti-
lize larger samples and include more stringently matched groups
along with healthy controls, as well as collect more comprehensive
measures of cognitive functioning and symptomatology.
In sum, the present findings are of direct clinical relevance for
two reasons: (1) both TBI in general and depression following TBI
are common, and (2) SPECT is a frequently used tool to investigate
cerebral abnormalities (44, 45). We found that SPECT perfusion
can differentiate among patients with MDD and mTBI but only
through using quantified measures of perfusion and not standard
clinical ratings. However, SPECT could not differentiate among
mTBI patients with or without depressive symptoms, suggesting
that it may only be useful with patients whose symptoms reach the
severity of a MDD.
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